Have you had a chance to watch the webinar? The timelines you suggest are off and the company specifically stated that today. They have no intention to sell or market this drug. They already have had interest in NNZ-2591 and the end goal is to get acquired or a license deal which is heavily front ended. This timeline is 18 months (at most). They also confirmed they are willing to take a deal now if the price is right. 18 months is based on the fact we will start PMS in Mid July and it is only a 3 month trial. If you include a few months lag for delays and patient recruitment there isn't much of a delay until top line results are read out. If these are results are strong we will gone before we have to go through the process of a NDA and ultimately approval. That timeline is much closer than you think IMO and if I am a betting man it will be either 2025 or 2026.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)